AICMCB2025 | Molecular Biology Conference | Cell Biology Conference | Synergia Summits | Prague

<!doctype html> <html class="no-js" lang="en"> <head>  <title>AICMCB2025 | Molecular Biology Conference | Cell Biology Conference | Synergia Summits | Prague | Top Conference in Molecular Biology</title> <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=1" /> <meta name="author" content="SynergySummits"> <link rel="icon" type="image/x-icon" href="https://synergiasummits.com/assets/images/favicon.png">  <meta name="description" content="AICMCB2025, Molecular Biology, Cell Biology, Biology, Genetics, Conference, Meeting, Symposium, Summit">  <meta name="keywords" content="">  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/animate.css" />  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/bootstrap.min.css" />  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/et-line-icons.css" />  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/font-awesome.min.css" />  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/themify-icons.css">  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/swiper.min.css">  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/justified-gallery.min.css">  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/magnific-popup.css" />  <link rel="stylesheet" type="text/css" href="https://aicmcb2025.synergiasummits.com/assets/revolution/css/settings.css" media="screen" /> <link rel="stylesheet" type="text/css" href="https://aicmcb2025.synergiasummits.com/assets/revolution/css/layers.css"> <link rel="stylesheet" type="text/css" href="https://aicmcb2025.synergiasummits.com/assets/revolution/css/navigation.css">  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/bootsnav.css">  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/style.css" />  <link rel="stylesheet" href="https://aicmcb2025.synergiasummits.com/assets/css/responsive.css" /> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.js"></script> <style> #loading { position: fixed; display: none; width: 100%; height: 100%; top: 0; left: 0; text-align: center; opacity: 0.7; background-color: #fff; z-index: 99; } #loading-image { position: absolute; z-index: 100; display: table; justify-content: center; top: 50%; left: 45%; } </style>  </head> <body> <div id="loading" > <img id="loading-image" src="https://aicmcb2025.synergiasummits.com/assets/images/ajax-loader.gif" alt="Loading..." /> </div>  <header class="header-with-topbar">  <div class="top-header-area bg-black"> <div class="container"> <div class="row padding-5px-tb"> <div class="col-md-6 col-sm-6 col-xs-12 text-white xs-text-small text-left alt-font xs-no-padding-lr xs-text-center"> <i class="ti-file"></i> First Round of Abstract Submission Ends: <span class="text-yellow xs-width-100 font-weight-600" title="">Dec 30, 2024</span> </div> <div class="col-md-6 col-sm-6 col-xs-12 xs-no-padding-lr text-right xs-text-small text-white"> <i class="ti-file"></i> Extended Early Bird Ends: <span class="text-yellow xs-width-100 font-weight-600" title="">Jul 30, 2024</span> </div> </div> </div> </div>   <nav class="navbar navbar-default bootsnav navbar-top nav-box-width"> <div class="container nav-header-container">  <div class="row"> <div class="col-md-2 col-xs-5"> <a href="https://aicmcb2025.synergiasummits.com" title="Synergy Summits" class="logo"> <img src="https://aicmcb2025.synergiasummits.com/assets/images/logo.png" data-rjs="https://aicmcb2025.synergiasummits.com/assets/logo@2x.png" class="logo-dark default margin-2px-top" alt="Synergy Summits"> <input type="hidden" id="confrance_start_date" value="2025-04-14" />  </a> </div>  <div class="col-md-9 col-xs-2 width-auto pull-right accordion-menu xs-no-padding-right"> <button type="button" class="navbar-toggle collapsed pull-right" data-toggle="collapse" data-target="#navbar-collapse-toggle-1"> <span class="sr-only">toggle navigation</span> <span class="icon-bar"></span> <span class="icon-bar"></span> <span class="icon-bar"></span> </button> <div class="navbar-collapse collapse pull-right" id="navbar-collapse-toggle-1"> <ul id="accordion" class="nav navbar-nav navbar-left no-margin alt-font text-normal" data-in="fadeIn" data-out="fadeOut">  <li><a href="https://aicmcb2025.synergiasummits.com">Home</a> <li><a href="https://aicmcb2025.synergiasummits.com/committee">Committee</a>  <li class="dropdown simple-dropdown"><a href="javascript:void(0);">Program <i class="fas fa-angle-down dropdown-toggle sm-no-display-none" data-toggle="dropdown" aria-hidden="true"></i></a><i class="fas fa-angle-down dropdown-toggle" data-toggle="dropdown" aria-hidden="true"></i>  <ul class="dropdown-menu" role="menu"> <li><a href="https://aicmcb2025.synergiasummits.com/plenary-speakers">Plenary Speakers</a></li> <li><a href="https://aicmcb2025.synergiasummits.com/keynote-speakers">Keynote Speakers</a></li> <li><a href="https://aicmcb2025.synergiasummits.com/programme-overview">Programme Overview</a></li> <li><a href="https://aicmcb2025.synergiasummits.com/download/schedule_pdf">Schedule</a></li> </ul> </li> <li class="dropdown simple-dropdown"><a href="javascript:void(0);">Submission <i class="fas fa-angle-down dropdown-toggle sm-no-display-none" data-toggle="dropdown" aria-hidden="true"></i></a><i class="fas fa-angle-down dropdown-toggle" data-toggle="dropdown" aria-hidden="true"></i>  <ul class="dropdown-menu" role="menu"> <li><a href="https://aicmcb2025.synergiasummits.com/call-for-abstracts">Call for Abstracts</a></li> <li><a href="https://aicmcb2025.synergiasummits.com/topics">Topics</a></li> <li><a href="https://aicmcb2025.synergiasummits.com/abstract">Submit Abstract</a></li> </ul> </li> <li class="dropdown simple-dropdown"><a href="javascript:void(0);">Registration <i class="fas fa-angle-down dropdown-toggle sm-no-display-none" data-toggle="dropdown" aria-hidden="true"></i></a><i class="fas fa-angle-down dropdown-toggle" data-toggle="dropdown" aria-hidden="true"></i>  <ul class="dropdown-menu" role="menu"> <li><a href="https://aicmcb2025.synergiasummits.com/registration-fee">Registration Fee</a></li> <li><a href="https://aicmcb2025.synergiasummits.com/registration-policies">Registration Policies</a></li> <li><a href="https://aicmcb2025.synergiasummits.com/register">Online Registration</a></li> </ul> </li> <li><a href="https://aicmcb2025.synergiasummits.com/sponsors">Sponsors</a> <li><a href="https://aicmcb2025.synergiasummits.com/awards">Awards</a> <li class="dropdown simple-dropdown"><a href="javascript:void(0);">Information <i class="fas fa-angle-down dropdown-toggle sm-no-display-none" data-toggle="dropdown" aria-hidden="true"></i></a><i class="fas fa-angle-down dropdown-toggle" data-toggle="dropdown" aria-hidden="true"></i>  <ul class="dropdown-menu" role="menu"> <li><a href="https://aicmcb2025.synergiasummits.com/venue">Venue</a></li> <li><a href="https://aicmcb2025.synergiasummits.com/code-of-conduct">Code of Conduct</a></li> </ul> </li> <li><a href="https://aicmcb2025.synergiasummits.com/contact">Contact</a> </ul> </div> </div> </div> </div> </nav>  </header>   <section class="wow fadeIn cover-background background-position-top top-space padding-25px-tb" style="background-image: url('https://aicmcb2025.synergiasummits.com/assets/images/about-banner.png')"> <div class="opacity-extra-medium"></div> <div class="container"> <div class="row"> <div class="col-md-12 col-sm-12 col-xs-12 display-table page-title-large"> <div class="display-table-cell vertical-align-middle text-left padding-30px-tb"> <h1 class="alt-font text-white font-weight-600 no-margin-bottom">Keynote Speakers</h1> </div> </div> </div> </div> </section>   <section class="wow fadeIn padding-25px-tb"> <div class="container"> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1714633336.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Teresa Pellegrino</div> <div class="text-medium font-weight-500 text-dark-gray">Italian Institute of Technology, Italy</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Magnetic Nanoparticle-based platforms to treat cancer and awake the immune system</font></div> <span class="more"> Teresa Pellegrino since 2014 is tenured team leader of the group of “Nanomaterials for Biomedical Applications” at the Italian Institute of Technology, Genoa, Italy. She received her PhD in Chemical synthesis in 2005 from the University of Bari. Her current research interests focus on the development of inorganic nanostructures for drug delivery, magnetic hyperthermia, photo-thermal treatment and radiotherapy applications. She is coauthor of 150 papers in peer review international journals. She is the recipient of H2020 ERC Consolidator grant “ Magnetic Hyperthermia for Metastasized Tumor Treatment and Remote Manipulation of Microdevice -GIULIa” N. 101044020 and the Investigator Grant received by the Italian Association of Cancer Research IG-AIRC-2023’ entitled ‘Magnetic scaffolds for tumor treatment: combining immunotherapy, differentiation therapy and mild magnetic hyperthermia </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1713871834.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Zhongsheng You</div> <div class="text-medium font-weight-500 text-dark-gray">Washington University in St. Louis, USA</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be updated soon</font></div> <span class="more"> Dr. Zhongsheng You is a tenured Professor in the Department of Cell Biology and Physiology at Washington University in St. Louis, School of Medicine. He has also co-directed the Molecular Cell Biology PhD Program at Washington University since 2019. Dr. You received his B.S. from Zhejiang University in China in 1994, M.S. from the Shanghai Institute of Biochemistry at the Chinese Academy of Sciences in 1997, and PhD from the University of California at San Diego in 2002. After completing postdoctoral training at the Salk Institute for Biological Studies in La Jolla, California, he joined Washington University as an assistant professor in 2009. During his PhD research with Professor John Newport, Dr. You uncovered novel mechanisms of cell cycle regulation by protein degradation and checkpoint pathways. His postdoctoral research with Professor Tony Hunter led to a major discovery regarding the activation mechanism of ATM, a tumor suppressor crucial for the cellular response to DNA double-strand break damage. At Washington University, Dr. You’s research focuses on on DNA and RNA surveillance mechanisms and their implications for cancer. In the DNA surveillance area, his work has yielded key insights into the intricate process of DSB resection, spanning initiation, elongation and termination phases. More recently, his lab has discovered a novel Ca2+-mediated signaling pathway that safeguards genome stability during replication stress. In the realm of RNA surveillance, his lab has developed multiple reporter systems for studying the nonsense-mediated RNA decay (NMD) pathway and has identified NMD as a potential therapeutic target in cancers with mutations in spliceosome factor genes. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1716012856.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Roi Gazit</div> <div class="text-medium font-weight-500 text-dark-gray">Ben-Gurion University of the Negev, Israel</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Exciting Hematopoietic Stem Cells</font></div> <span class="more"> Roi Gazit, PhD. is a Principal Investigator of Hematopoietic Stem Cell (HSC) and Immunology at the Ben-Gurion University of the Negev since 2013. He is an active member of NIBN, ISCS, IIS, and ISEH. Roi earned a B.Sc. and M.Sc. in life science and developmental biology from the Hebrew University of Jerusalem. PhD in immunology, under supervision of Ofer Mandelboim, studying NK-cell in vivo, including the generation of the first NK specific mouse model and elucidation of novel NK-cell abnormalities in human. Postdoc at Harvard Medical School, Derrick Rossi laboratory, focusing on the identification and utilization of HSCs’ genes, including reprogramming and generation of a novel HSC-reporter mouse. His laboratory at the Ben-Gurion University is studying HSCs’ transcriptome along normal development and during immune-challenges </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1716014610.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Adriana Ioana Colovai</div> <div class="text-medium font-weight-500 text-dark-gray">USA</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be updated soon</font></div> <span class="more"> I am an associate professor of Pathology and director of Cellular Immunology and Immunogenetics laboratories at Montefiore Medical Center in New York. My research interests encompass tumor immunology and transplantation. Before joining Montefiore, I studied the structure and function of HLA-bound peptides in the Immunogenetics Laboratory at Columbia University, under the mentorship of Dr. Nicole Suciu-Foca. Our results have advanced the understanding of the role of these peptides as allo- and tumor antigens. In my quest for new tumor antigens, I also studied the function and prognostic value of cellular markers overexpressed in hematological malignancies. My current research is focused on hematopoietic stem cell transplantation and development of new tools to monitor minimal residual disease, with the goal of preventing relapse and improving transplant outcomes. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1716360495.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Beatriz Fontoura</div> <div class="text-medium font-weight-500 text-dark-gray">USA</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be updated soon</font></div> <span class="more"> Dr. Beatriz Fontoura received her Ph.D. degree in Basic Biomedical Sciences from New York University School of Medicine. For her post-doctoral training, Dr. Fontoura joined the Laboratory of Cell Biology at The Rockefeller University under the mentorship of Dr. Gunter Blobel. Dr. Fontoura is currently a Professor in Department of Cell Biology at University of Texas Southwestern Medical Center. She has the endowed title of Ruth S. Harrell Professorship in Medical Research. She is currently a member of the Pew Foundation National Advisory Committee. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1717752581.png" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Michael Sherman</div> <div class="text-medium font-weight-500 text-dark-gray">Ariel University, Israel</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be updated soon</font></div> <span class="more"> Dr. Sherman holds a doctoral degree from Moscow University. He worked as a postdoctoral fellow at Harvard University. In 1995, he started his lab at Boston Biomedical Research Institute. From 2001 to 2005 he was Associate professor at Boston University, and from 2005 to 2018 Full professor at this institute. From 2010-2015, he was a Program Leader at BU Cancer Center. His working field includes the role of molecular chaperones in cancer development, as well as mechanisms of senescence and development of drug resistance with emphasis on DNA repair. He is an author of more than 120 original and review papers and book chapters. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1717821441.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Vanessa Sperandio</div> <div class="text-medium font-weight-500 text-dark-gray">USA</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be updated soon</font></div> <span class="more"> Vanessa Sperandio is the Chair of the Department of Medical Microbiology and Immunology in the University of Wisconsin-Madison and the Robert Turell Professor. She was the Jane and Bud Smith Distinguished Chair in Medicine, and a Professor in the departments of Microbiology and Biochemistry at UT Southwestern Medical Center. She got her bachelors in biology, and her masters and PhD in Molecular Genetics in the State University of Campinas (UNICAMP) in Brazil. She was a Latin American Pew Fellow in Biomedical Sciences (1997), an Ellison Foundation New Scholar (2004), a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases (2006), and a National Academy Kavli Frontiers of Science Fellow (since 2007). She is the recipient of the ASM 2015 Eli Lilly and Company-Elanco Research award, and a winner of the 2014 GSK Discovery Fast-track challenge. In 2013 she was elected a fellow of the American Academy of Microbiology (AAM) and is the Chair of the Board of Governors of the AAM. She was elected as an American Association for the Advancement of Sciences (AAAS) fellow in 2022. Her research investigates chemical, stress and nutritional signaling at the interface amongst the mammalian host, beneficial microbiota and invading bacterial pathogens. The main tenant of research in her laboratory is the study of how bacterial cells sense several mammalian neurotransmitters leading to rewiring and reprogramming of bacterial transcription towards host and niche adaptation. She has also identified several bacterial receptors to mammalian neurotransmitters and reported that invading pathogens hijack these inter-kingdom signaling systems to promote virulence expression. She also translated these basic science concepts into strategies to develop novel approaches to anti-microbial therapy. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1718090252.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Baruch Minke</div> <div class="text-medium font-weight-500 text-dark-gray">Israel</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Nociception and pain in humans lacking functional TRPV1 channel</font></div> <span class="more"> Baruch Minke has created a new field of research. He co-discovered a new type of ion channel, which he designated the Transient Receptor Potential or in short, the TRP channel, as a result of his studies on phototransduction and vision in fruit flies (Drosophila melanogaster). He investigated the biophysical and biochemical properties of TRP channels in fruit fly eyes and identified together with the late Prof. Zvi Selinger phospholipase C as a crucial component of the Drosophila TRP signaling pathway. Today he has extended his research to the first identified loss of function mutation in human TRPV1 channel that govern at least several of the human body’s regulatory processes related inflammatory pain and to noxious heat detection. His major aim is to decipher the critical roles of TRP channels in invertebrate vision and of TRPV1 in human somatosensory physiology. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1718280900.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Ryan J. Mailloux</div> <div class="text-medium font-weight-500 text-dark-gray">Canada</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Flavin-dependent dehydrogenases as key sources of mitochondrial hydrogen peroxide (mtH2O2): implications in understanding the manifestation and treatment of liver diseases</font></div> <span class="more"> Professor Ryan J. Mailloux joined McGill University in 2019 and is currently the Director of the School of Human Nutrition. His research aims to understand how mitochondria generate free radicals and use these reactive molecules in cell communication. Specifically, his work focuses on mitochondrial hydrogen peroxide in the liver, the redox regulatory mechanisms that control its production, and how controlled mitochondrial hydrogen peroxide production can be used it to maintain optimal liver health through the induction of oxidative eustress signals. His research also focuses on exploring the consequences of dysfunctional mitochondrial redox communication in the induction of hepatic oxidative distress and how this triggers the manifestation of non-alcoholic fatty liver disease and its progression to hepatocellular carcinoma. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1718365852.png" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Jian Zhang</div> <div class="text-medium font-weight-500 text-dark-gray">The Fourth Military Medical University, China</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be update soon</font></div> <span class="more"> Professor Zhang is currently the director of the Department of Biochemistry and Molecular Biology of Fourth Military Medical University, and the PI of State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers. He is mainly engaged in the molecular mechanism research of cancer drug resistance and malignant transformation of inflammation to cancer. He has presided over one national "863" young scientist project, seven projects of National Natural Science Foundation and Shaanxi Outstanding Youth Fund, and other projects. He has obtained 1 PCT patent authorization of USA and 2 invention patent authorization of China. He published 52 SCI papers in J Clin Invest, Science Adv, Mol Therapy and other authoritative journals as corresponding/co-corresponding author. There are 3 papers obtained Top 1% ESI highly cited papers. He has won the second prize of National Science and Technology Progress, the First Prize of Science and Technology of Shaanxi Province, the Chinese Medical Youth Science and Technology Award. He is currently serving as Vice chairman and Secretary-General of Shaanxi Biochemical Society and member of Metabolism Committee of Chinese Cell Biology Society. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1718773067.png" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. M. Benjamin Major</div> <div class="text-medium font-weight-500 text-dark-gray">Washington University School of Medicine, USA</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be updated soon</font></div> <span class="more"> Research Interests Studying how perturbation of specific signal transduction pathways contributes to the initiation, progression and dissemination of cancer. Professional Education BS: Michigan State University, 1997, Microbiology and Virology PhD: University of Utah, 2004, Oncological Sciences Postdoc: University of Washington, 2004-2009, Proteomics </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1721637564.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Lars Larsson</div> <div class="text-medium font-weight-500 text-dark-gray">Sweden</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Experimental and clinical studies of Critical Illness Myopathy: Underlying mechanisms and intervention strategies</font></div> <span class="more"> I have the expertise, training, and leadership necessary to successfully complete the proposed research project. A statement based on my research focusing on regulation of muscle contraction at the whole muscle, motor unit, muscle cell and motor protein levels in health and disease in experimental and clinical studies, i.e., research conducted at different European and US universities since more than 45 years. This research has involved the modification/development of novel methods allowing detailed analyses of motor unit, muscle cell and myosin function and structure in different mammalian species, including humans. A strong focus has been on the function and regulation of the molecular motor protein myosin. After diagnosing the first intensive care unit (ICU) patient in Scandinavia with critical illness myopathy (CIM) while being on call Christmas 1995, the research in my group is focusing on improving our understanding of basic underlying mechanisms, improving diagnosis and monitoring, implementing, and evaluating intervention strategies of CIM in experimental models and clinical studies, and translating promising interventions to the clinic. This work has involved the modification of a very powerful and unique rat experimental model not limited by early mortality. I have collaborated with Dr. Dworkin using this model for more than two decades, originally at the Pennsylvania State University (PSU), later at Uppsala University and currently at Karolinska Institutet (KI). After his retirement from PSU, Dr. Dworkin joined my research group in Sweden and we now have the only two models of this experimental set-up available worldwide allowing us to conduct two long-term studies in parallel. The hallmark of CIM is the preferential loss of the motor protein myosin, but we have also shown that the ICU condition induces significant post-translational modifications of myosin with a strong negative impact on myosin function. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1722661055.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Sang-Bing Ong</div> <div class="text-medium font-weight-500 text-dark-gray">Chinese University of Hong Kong, Hong Kong</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be updated soon</font></div> <span class="more"> Prof Sang-Bing Ong has been leading research studying the roles of cardiac mitochondrial dynamics in cardioprotection. He received his Bachelor’s degree in Malaysia, a Masters and a PhD in London UK followed by postdoctoral research in San Diego and Singapore. He was a Hitachi Fellow in Hokkaido Japan and a Thailand MHESI’s Visiting Professor. He has held academic positions in Malaysia, Singapore and is now heading the Mitochondria@HeartHK laboratory at the Department of Medicine & Therapeutics and Centre for Cardiovascular Genomics and Medicine at the Chinese University of Hong Kong </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1723609844.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Andreas Bergmann</div> <div class="text-medium font-weight-500 text-dark-gray">USA</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Genetic control of apoptosis-induced proliferation in Drosophila.</font></div> <span class="more"> Prof. Bergmann performed his doctoral thesis in the laboratory of Prof. Christiane Nüsslein-Volhard at the Max-Planck-Institute in Tübingen/Germany and obtained his doctorate degree in 1996. He received postdoctoral training in the laboratory of Prof. Hermann Steller at Massachusetts Institute of Technology (MIT) in Cambridge, MA/USA. After that, he became an independent investigator at MD Anderson Cancer Center in Houston, TX/USA in 2000. In 2011, he moved into his current position at UMass Chan Medical School in Worcester/MA/USA where he holds the rank of Professor. There, he studies the genetic control of programmed cell death (apoptosis), oncogenes and tumor suppressor genes in the genetic model organism Drosophila melanogaster. Combining genetics, cell and molecular biology as well as biochemical approaches, his goal is to use the tools available in Drosophila to embrace the biological complexity of apoptosis control and its effects on neighboring cells in multi-cellular organisms during development and pathogenesis. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1724303185.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Nullin Divecha</div> <div class="text-medium font-weight-500 text-dark-gray">Uk</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Nuclear phosphoinositide signaling and its role in controlling cell fate decisions</font></div> <span class="more"> Will be updated soon </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1724737856.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Alexander Sorkin</div> <div class="text-medium font-weight-500 text-dark-gray">USA</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">EGF receptor endocytosis: mechanisms and role in signaling</font></div> <span class="more"> Alexander Sorkin did his post-doctoral training at the Vanderbilt University and then started independent research as an Assistant professor at the University of Colorado where he went through the rank to become a Professor of Pharmacology. In 2010, he joined the University of Pittsburgh as Richard Beatty Mellon Professor and Chair of the Department of Cell Biology where he continues in this role at the present time. </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1726057640.jpg" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Prof. Winfried Weissenhorn</div> <div class="text-medium font-weight-500 text-dark-gray">Université Grenoble Alpes, France</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Cleaving membranes with ESCRTs and beyond</font></div> <span class="more"> Winfried Weissenhorn is a Professor of Biochemistry and Structural Biology at the University Grenoble Alpes, Director of the Institute of Structural Biology (IBS) in Grenoble and principal investigator of a research group focusing on the structural biology of HIV-1 entry and cellular complexes recruited for budding. He received his PhD in Biochemistry in 1991 from the Ludwig Maximilians University in Munich and performed his post-doctoral training in structural biology at Harvard University. Before he joined IBS in 2015, he was group leader in structural Biology at the EMBL (1998-2006) and the UVHCI (2007-2014) in Grenoble. He received the Line Renaud award from the FRM (Fondation pour la Recherche Médicale en France) in 2011 and he is a senior member (promotion 2012) of the “Institut Universitaire de France” </span> </div> </div> <div class="row border-all border-color-blue padding-15px-tb margin-30px-bottom"> <div class="col-md-3 col-sm-6 col-xs-12 team-block text-left team-style-1 sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <figure> <div class="team-image xs-width-100"> <a href="#"><img src="https://aicmcb2025.synergiasummits.com/storage/speakers/1737533210.png" alt="" data-no-retina=""></a> </div> </figure> </div> <div class="col-md-9 col-sm-6 col-xs-12 text-left sm-margin-two-bottom xs-margin-20px-bottom wow fadeInRight"> <div class="font-size-26px font-weight-600 text-extra-dark-gray">Dr. Dasiel Oscar Borroto Escuela</div> <div class="text-medium font-weight-500 text-dark-gray">Karolinska Institute, Sweden</div> <div class="text-extra-large font-weight-500 text-blue margin-10px-top margin-20px-bottom">Title: <font class="text-light-blue text-italic">Will be updated soon</font></div> <span class="more"> I am focused on understanding how receptor-receptor interactions in heteroreceptor complexes integrate signals in the brain and contribute to the development of brain diseases such as Parkinson’s, schizophrenia, addiction, and depression. My work explores these complexes as potential therapeutic targets for psychiatric and neurological disorders. My work also involves developing and refining innovative methods to better describe these interactions, such as in situ proximity ligation assays (PLA) and adaptations of Light Resonance Energy Transfer (LRET)-based techniques to study GPCR oligomerization dynamics in neurons and heterologous systems. Throughout my career, I have pioneered key discoveries in the field, including the identification of GPCR-GPCR and GPCR-RTK receptor-receptor interactions and their allosteric effects in the central nervous system (CNS). I introduced the concept that these interactions may form the molecular basis for learning and memory, and I have also proposed that alterations in GPCR heterocomplexes play a role in mental disorders and neurodegenerative diseases. My research has led to novel therapeutic approaches, including the development of small interfering peptides that target receptor interfaces in heterocomplexes. My contributions have been acknowledged through awards such as the ECNP Fellow Award and the I3 Research Certifiation. My ongoing commitment is to advance the study of heteroreceptor complexes and their role in brain diseases, providing innovative insights and therapeutic avenues for CNS disorders </span> </div> </div> </div> </section>  <script> var showChar = 300; // How many characters are shown by default var ellipsestext = "..."; var moretext = '<font class="btn btn-very-small btn-transparent-dark-gray btn-rounded md-margin-15px-bottom sm-display-table sm-margin-lr-auto margin-10px-top float-right" href="#">Show More</font>'; var lesstext = '<font class="btn btn-very-small btn-dark-gray btn-rounded md-margin-15px-bottom sm-display-table sm-margin-lr-auto margin-10px-top float-right" href="#">Show Less</font>'; $(document).ready(function(){ $('.more').each(function() { var content = $(this).html(); if(content.length > showChar) { var c = content.substr(0, showChar); var h = content.substr(showChar, content.length - showChar); var html = c + '<span class="moreellipses">' + ellipsestext+ ' </span><span class="morecontent"><span>' + h + '</span>  <a href="" class="morelink">' + moretext + '</a></span>'; // html = 'testing'; $(this).html(html); } }); $(".morelink").click(function(){ if($(this).hasClass("less")) { $(this).removeClass("less"); $(this).html(moretext); } else { $(this).addClass("less"); $(this).html(lesstext); } $(this).parent().prev().toggle(); $(this).prev().toggle(); return false; }); }) </script>  <footer class="footer-classic-dark bg-extra-dark-gray"> <div class="bg-dark-footer padding-15px-tb xs-padding-10px-tb"> <div class="container"> <div class="row equalize xs-equalize-auto"> <div class="col-md-4 col-sm-5 col-xs-12 text-center alt-font display-table xs-text-center xs-margin-15px-bottom" style="height: 93px;"> <div class="display-table-cell vertical-align-middle text-white"> We build effective Summits... </div> </div> <div class="col-md-4 col-sm-2 col-xs-12 text-center display-table xs-margin-10px-bottom" style="height: 93px;"> <div class="display-table-cell vertical-align-middle"> <a href="#"><img class="footer-logo" src="https://aicmcb2025.synergiasummits.com/assets/images/logo_footer.png" data-rjs="https://aicmcb2025.synergiasummits.com/assets/images/logo_footer.png" alt="Synergy Summits" data-rjs-processed="true"></a> </div> </div> <div class="col-md-4 col-sm-5 col-xs-12 col-xs-12 text-center display-table xs-text-center" style="height: 93px;"> <div class="display-table-cell vertical-align-middle"> <span class="alt-font margin-20px-right text-white">On social networks</span> <div class="social-icon-style-8 display-inline-block vertical-align-middle"> <ul class="small-icon no-margin-bottom"> <li><a class="twitter text-white" href="https://twitter.com/https://twitter.com/synergiasummits" target="_blank"><i class="fab fa-twitter"></i></a></li> <li><a class="linkedin text-white" href=" https://www.linkedin.com/" target="_blank"><i class="fab fa-linkedin"></i></a></li> </ul> </div> </div> </div> </div> </div> </div> </footer> <footer class="footer-classic-dark bg-white"> <div class="padding-two-tb xs-padding-10px-tb"> <div class="container"> <div class="row equalize xs-equalize-auto"> <div class="col-md-5 col-sm-6 col-xs-12 widget border-right border-color-extra-light-gray padding-45px-left sm-padding-15px-left sm-clear-both sm-no-border-right xs-margin-30px-bottom xs-text-center"> <div class="widget-title alt-font text-large text-extra-dark-gray text-uppercase margin-10px-bottom font-weight-600">Contact Info</div> <p class="font-size-15px display-block margin-15px-bottom width-80 sm-width-70 xs-center-col"> <b>Synergia Summits Private Limited.</b><br/> Flat No-3006, Block No-2, My Home Avatar,<br/> Puppalaguda, Narsingi, Gandipet Mandal,<br/> Rangareddy, Hyderabad, Telangana,<br/> India, PIN-500089. </p> <div class="font-size-15px"><b>Email:</b> <a href="mailto:aicmcb2025@synergiasummits.com">aicmcb2025@synergiasummits.com</a></div> <div class="font-size-15px"><b>Phone:</b> +91-9885-871-872</div> </div> <div class="col-md-4 col-sm-6 col-xs-12 widget border-right border-color-extra-light-gray sm-no-border-right sm-margin-30px-bottom xs-text-center"> <div class="widget-title alt-font text-large text-extra-dark-gray text-uppercase margin-10px-bottom font-weight-600">Twitter Feeds</div> <div style="width:100%; height:300px;overflow: scroll"> <a class="twitter-timeline" href="https://twitter.com/https://twitter.com/synergiasummits?ref_src=twsrc%5Etfw">Tweets by https://twitter.com/synergiasummits</a> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script> </div> </div> <div class="col-md-3 col-sm-6 col-xs-12 widget padding-45px-left sm-padding-15px-left xs-text-center"> <div class="widget-title alt-font text-large text-extra-dark-gray text-uppercase margin-10px-bottom font-weight-600">Services</div> <ul class="list-unstyled"> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com">Home</a> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com/committee">Committee</a> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com/programme-overview">Program Overview</a></li> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com/abstract">Abstract Submission</a></li> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com/register">Registration</a></li> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com/sponsors">Sponsors</a> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com/awards">Awards</a> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com/venue">Venue</a></li> <li><a class="text-medium text-decoration-underline" href="https://aicmcb2025.synergiasummits.com/contact">Contact</a></li> <li><a class="text-medium text-decoration-underline" href="http://synergiasummits.com/terms-and-conditions">Terms of Use</a></li> <li><a class="text-medium text-decoration-underline" href="http://synergiasummits.com/privacy-policies">Privacy Policies</a></li> </ul> </div> </div> </div> </div> </footer> <footer class="bg-yellow"> <div class="bg-yellow padding-25px-tb text-center xs-padding-15px-tb"> <div class="container"> <div class="row">  <div class="col-md-6 col-sm-6 col-xs-12 text-left text-black text-small xs-text-center">© 2023 <a href="#" target="_blank" class="text-black font-weight-800">Synergia Summits Pvt Ltd,</a> All Rights Resetved.</div>   </div> </div> </div> </footer>   <a class="scroll-top-arrow" href="javascript:void(0);"><i class="ti-arrow-up"></i></a>   <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/modernizr.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/bootstrap.min.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.easing.1.3.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/skrollr.min.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/smooth-scroll.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.appear.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/bootsnav.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.nav.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/wow.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/page-scroll.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/swiper.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.count-to.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.stellar.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.magnific-popup.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/isotope.pkgd.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/imagesloaded.pkgd.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/classie.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/hamburger-menu.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/counter.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.fitvids.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/equalize.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/skill.bars.jquery.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/justified-gallery.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/jquery.easypiechart.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/instafeed.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/retina.min.js"></script>  <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/revolution/js/jquery.themepunch.tools.min.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/revolution/js/jquery.themepunch.revolution.min.js"></script> <script type="text/javascript" src="https://aicmcb2025.synergiasummits.com/assets/js/main.js"></script> <script type="text/javascript" src="https://cdn.jsdelivr.net/npm/jquery-validation@1.19.5/dist/jquery.validate.js"></script> <script src="https://cdn.jsdelivr.net/npm/jquery-validation@1.19.5/dist/additional-methods.min.js"></script> <script src="https://unpkg.com/sweetalert/dist/sweetalert.min.js"></script> </body> </html>

CINXE.COM

AICMCB2025 | Molecular Biology Conference | Cell Biology Conference | Synergia Summits | Prague | Top Conference in Molecular Biology